GPT and metabolic dysfunction-associated steatotic liver disease: The AUROC (0.80-0.86) for predicting advanced fibrosis was also highest for the FIB-4 index as compared to other non-invasive markers (AST/ALT ratio, NAFLD-fibrosis score and BARD score) [21].